Design of a Probe for Neuraminidase to Capture and Identify Influenza Viruses Shih-Hsiung Wu Institute of Biological Chemistry, Academia Sinica, Taipei,

Slides:



Advertisements
Similar presentations
Rust et al 2004Troels Scheel Single molecule biophysics Assembly of endocytic machinery around individual influenza viruses during viral entry Influenza.
Advertisements

1 Antiviral Drugs Limited selective toxicity –Viruses mostly use host cell machinery, so very few unique targets –Most drugs block steps that take place.
Chapter 23.  Agents that cause disease  Many microorganisms: bacteria, fungi, protozoa  Bacteria are prokaryotes, but only a few are pathogens; most.
80% Influenza A — H3N2 (some H1N1) 20 % influenza B (orthomyoxiviridae – seals and humans only) Deaths above epidemic threshold – 50% hospitalizations.
Influenza Sara Finestone April 8, The influenza virus causes 3-5 million cases of severe illness and up to 500,000 deaths annually.
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
Enzyme Assays on Chips. Introduction Enzyme assays are used for discovery and characterization of enzymes Identification of protein function instead of.
HIV and AIDS Human Immunodeficiency Virus (HIV) is the virus that causes Acquired Immunodeficiency Syndrome (AIDS).
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
Antibody Activity Against Sialidase Used as a Potential Therapeutic Treatment for Autoimmune Disorders Amber Williams, Department of Biology, York College.
Experimental systems in Immunology Sadegh Babashah, PhD Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University.
Introduction to the Viruses: General properties of viruses: 1-They are very small in size, from  m. 2-They contain one kind of nucleic acid (RNA.
Viruses Part II. It was not until the 1950s that scientists were able to isolate and identify how viruses multiplied in a host It was not until the 1950s.
THE INFLUENZA VIRUS. RNA virus Family: Genus: Types: Classification Type AType B Influenza virus Type C Influenza C virus ORTHOMYXOVIRIDAE Kingsbury DW.
Antibody Fab region bound to a sequential antigen
Viruses Chapter Nature of Viruses All viruses have same basic structure -Nucleic acid core surrounded by capsid Nucleic acid can be DNA or RNA;
Antiviral Chemotherapy Discovery of antiviral drugs Targets of antiviral drugs.
In God We Trust.
Viruses Chapter 19. A Borrowed Life Virus: an infections particle incapable of replicating outside of a cell, which consists of an RNA or DNA genome enclosed.
Enzyme-Linked Immunosorbent Assay [ELISA] BCH 462[practical] Lab#5.
Misconduct Case Study Our story so far: Peter:4 th -year grad. student makes mice lacking SLAM gene several cell types have abnormal function Sally:4 th.
ELISA Assay. What Is It? Enzyme immunoassay (EIA) is a test used to detect and quantify specific antigen-eliciting molecules involved in biological processes,
27 MAR 2007 Antiviral Drugs: An Overview Chris Brooks CHEM 5398 Medicinal Chemistry Prof. Buynak.
Médicaments anti-influenza Présentation réalisée en partie au départ des exposés donnés à l'UCL en par le Prof. E. De Clerq (Rega Instituut,
Influenza A/H1N1 W. Rose H1N1 is a subtype of influenza type A Influenza types B and C also exist but less common, less infectious, and drift.
The Flu Pandemic of 1918 The “Spanish flu” pandemic that swept around the world from June 1918 to December 1919 killed between 50 and 100 million people.
1 Antimicrobial Drugs. 2 Antimicrobal Chemotherapy Terms.
Viruses. Biology of Viruses Structure of Viruses: Size -Less then 0.2 microns Parts of the Virus 1)Capsid: -Made of protein subunits 2) Inner core: made.
Discussion 22 Inhibitors and Drugs. Questions 1.Explain how an inhibitor of glutamine:fructose aminotransferase (GFAT) would affect glycosylation? 2.From.
Review: Viruses Virus Genome Polarity Segments Morphology Enveloped Diseases Picorna RNA +ss 1 Icosahedral No Polio, Hepatitis A, Colds Toga RNA +ss 1 Icosahedral Yes Encephalitis,
Antiviral Agents, chapter 39 Different living organisms.
Characterizing and Classifying Viruses and Prions
Influenza H1N1 A: A close insight Dr. Mustafa Ababneh Molecular Virologist.
professor in microbiology
Vaccines: A Molecular View
In the name of God. Summer School Influenza Unit, Pasteur Institute of Iran summer 2013 Summer School.
Fig µm Chapter 19. Fig (a) The 1918 flu pandemic (b) Influenza A H5N1 virus (c) Vaccinating ducks 0.5 µm.
 Recognition  Attachment  Penetration  Uncoating  Early protein synthesis  Nucleic acid synthesis  Late protein synthesis  Assembly  Release.
Two different therapeutic approaches for treating: A.A DNA virus (e.g. Herpes) B.An RNA virus (e.g. Influenza)
Virologia Applicata E.A. Influenza VIROLOGIA. Virologia Applicata E.A. Influenza The virus and its replication.
Bio 1010 Dr. Bonnie A. Bain 1.
V i r u s e s Non-Living.
Reverse Genetics of RNA Viruses. Reverse Genetics (RG) The creation of a virus with a full- length copy of the viral genome The creation of a virus with.
Lecture 4 clinical practice Laboratory techniques in virology Dr. dalia galal.
 Virus: A biological particle composed of nucleic acid and protein  Intracellular Parasites: organism that must “live” inside a host.
VIROLOGY The Study of Viruses. Virology 1.Definition: A submicroscopic acellular pathogen composed only of protein and one type of nucleic acid.
Pharmaceutical Approaches to Antiviral Drug Discovery
Lecture 35: Common Viral Diseases DR. N. JEYAKUMAR UNIT OF MICROBIOLOGY MBBS ( BATCH-17)
Orthomyxoviruses Orthomyxoviridae
Antivirals Essential idea
Orthomyxoviridae Is enveloped virus, helical nucleocapsid
Antiviral Medications
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
Higher Affinity Heptapeptides Against Influenza Hemagglutinin-Sialic Acid Identification for Treating Flu Virus Disease Ahmed ”e” Al Qaffas.
THE INFECTIOUS PROCESS FOR A VIRUS Despite their simplicity relative to bacteria, viruses still possess various biochemical targets for potential attack.
Orthomyxoviridae Molecular Virology.
Outline Introductory Comments Origins of HIV
Antivirals Essential idea
Introduction to Virology
Bacteria and Viruses Viruses.
Antivirals Essential idea
A typical enveloped virus
HCV NS5A Inhibitors: The Devil Is in the Details
Zachary Shriver, Rahul Raman, Karthik Viswanathan, Ram Sasisekharan 
Viruses Viruses – are segments of nucleic acids
Volume 3, Issue 4, Pages (April 2013)
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
TIGP program in Chemical Biology (April, )
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Volume 17, Issue 3, Pages (March 2015)
Presentation transcript:

Design of a Probe for Neuraminidase to Capture and Identify Influenza Viruses Shih-Hsiung Wu Institute of Biological Chemistry, Academia Sinica, Taipei, TAIWAN

Influenza A Virion Two glycoproteins : Hemagglutinin (HA, 80%) A trimeric protein that functions in the attachment of the virus to host cells. –14 major types Neuraminidase (NA, 20%) A tetrameric protein which is involved in facilitating the release of newly produced virus particles from host cell. –9 major types The Lancet 355 (2000) 827

Replicative cycle of Influenza virus The Lancet 355(2000) 827

Influenza Virus Neuraminidase Inhibitors NameManufacturerRoute 1 Zanamivir (Relenza) GlaxoInhalation 2 Oseltamivir (Tamiflu) RocheOral Two drugs that FDA approved : 12 Sialic Acid

Neuraminidase Inhibitor Normal assembly and budding of virus Lateral aggregation and formation of large bundles by virus Absence of NA inhibitorPresence of NA inhibitor The Lancet 355 (2000) 827

Zanamivir-Biotin Conjugates as Non-covalent Capture Ligand All three conjugates are good inhibitors of influenza NA. The compound successfully captured influenza A virus was demonstrated by ELISA method. Dr. J. L. McKimm-Breschkin et al. Angew. Chem. Int. Ed. 42 (2003)

Nature 437 (2005) 1108 Relenza probably lost its binding ability for drug-resistant mutants Is it possible to design a probe for capturing not only wild-type influenza viruses but also its mutant viruses? Generation of Drug-resistant Mutants

Mechanism-Based Inhibitor or probe for Glycosidase Suicide substrate inhibitors –  -Glucosidase Danzin et al –Neuraminidase Quash et al Ki=1.7 mM Ki=3.7 mM Ki=0.15 mM

Activity Probes –N-Acetylglucosaminidase Ichikawa et. al. (2001) –  -Glucosidase L.-C. Lo et al. (2002) –  -Galactosidase S. Nishimura, Y.-C. Lee et al. (2004) Neuraminidase (Vibrio cholerae) S. Nishimura et al., (2005) Mechanism-Based Inhibitor or probe for Glycosidase

RecognitionReporterLinker group Latent reactive Hydrolytic Activity Probes vs Suicide Substrates Activity Probes Recognition group Latent reactive Suicide Substrates

Design of a Mechanism-Based activity probe for Neuraminidase Sialic acid biotin The biotin group serves as a reporter (or tracer) : 1. Western blotting : it is used to visualize the labeled NA with streptavidin - conjugated peroxidase chemiluminescence. 2. Virus-capturing study by ELISA method

Mechanism of neuraminidase activity probe

Synthesis of activity probe for Neuraminidase Conditions: (i) MeOH, IR-120 (H + ) resin, 92 %; (ii) AcCl, AcOH; (iii) 2-hydroxy-5-nitrobenzaldehyde, Cs 2 CO 3, Bu 4 NBr, H 2 O-CHCl 3, 67 % for two steps; (iv) DAST, CH 2 Cl 2, 47 %; (v) H 2, 5% Pd/C, MeOH, 95 %; (vi) succinic ahydride, TEA, CH 2 Cl 2, 94 %

Conditions: (vii) EDCI, HOBt, 8, DIEA, DMF, 75 %; (viii) Na 2 CO 3, MeOH; aqueous Na 2 CO 3, 52 %.

Neuraminidase labeling assay NA : Arthrobacter ureafaciens neuraminidase Three biotinylated bands corresponding to isoenzymes at 88, 66, and 52 KDa were observed. The probe had no effect on BSA. In the absence of the probe, neither NA nor BSA was biotinylated. Western blotting

Mechanism-Based inhibition AU : Arthrobacter ureafaciens CP : Clostridium perfringens VC : Vibrio cholerae Inf A : influenza A virus probe and zanamivir : 3.3 mM  Zanamivir : transition state analog  NA Probe : mechanism-based inhibitor * * *

The Capture and Identification of Influenza Virus ELISART-PCR Anti-HA Ab IgG-HRP

The Detection of influenza A virus by ELISA NA probe could successfully capture influenza A virus and the intensity of the responding signal was proportional to the number of virus particles. Only influenza A virus was selectively captured and detected on the plate as compared with non-NA containing Japanese encephalitis virus (JEV).

RT-PCR Template Vol. RNA isolation RT-PCR (nucleoprotein) SYBR Safe TM Gel Stain A/WSN/33 NP 307 bp Virus particles (PFU) 500 NP 307 bp

Application of NA activity probe Activity probe for detection of microorganism –Virus Orthomyxoviridae (influenza virus) Paramyxoviridae (Newcastle disease virus, Sendai virus, parainfluenza virus, Mumps virus, porcine rubulavirus virus) –Pathogenic bacteria or parasite Clostridium perfringens Vibrio cholerae Shigella dysenteriae Salmonella typhimurium Streptococcus pneumoniae Trypanosoma cruzi

Application of activity-based probe Tumor Target Discovery Novel Enzyme Discovery Detection of Microorganism Inhibitor Discovery Characterization of Enzyme Mechanism Activity-based probe Proteomics